drugset / Trial / NCT07568275
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
Phase 0
Active not recruiting
30 enrolled
The Cleveland Clinic
Innoviva Specialty Therapeutics · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure. The investigators want to find out if Angiotensin II can help the heart and blood vessels work together more effectively than standard treatments.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2028-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Angiotensin II | Peptide | 2.5 mg/ml | — |